Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Diagnostic Efficacy of Rapid Antigen Testing for SARS-CoV-2: The COVid-19 AntiGen (COVAG) study

View ORCID ProfileChristoph Wertenauer, View ORCID ProfileGeovana Brenner Michael, View ORCID ProfileAlexander Dressel, View ORCID ProfileCaroline Pfeifer, Ulrike Hauser, View ORCID ProfileEberhard Wieland, Christian Mayer, Caren Mutschmann, Martin Roskos, Hans-Jörg Wertenauer, View ORCID ProfileWinfried März
doi: https://doi.org/10.1101/2021.08.04.21261609
Christoph Wertenauer
1Hausärzte am Schillerplatz, Hauptstraße 5, 70563 Stuttgart-Vaihingen, Germany
2Medical Clinic V, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany
3Riga Stradins University, Dzirciema iela 16, LV-1007 Riga, Latvia
4SYNLAB Holding Deutschland GmbH, Gubener Straße 39, 86156 Augsburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christoph Wertenauer
  • For correspondence: christoph.wertenauer@aerzteschillerplatz.de
Geovana Brenner Michael
4SYNLAB Holding Deutschland GmbH, Gubener Straße 39, 86156 Augsburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Geovana Brenner Michael
Alexander Dressel
5Dr. Dressel Consulting, Am Exerzierplatz 23, 68167 Mannheim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alexander Dressel
Caroline Pfeifer
4SYNLAB Holding Deutschland GmbH, Gubener Straße 39, 86156 Augsburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Caroline Pfeifer
Ulrike Hauser
6SYNLAB Medical Care Center Augsburg GmbH, Gubener Straße 39, 86156 Augsburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eberhard Wieland
7SYNLAB Medical Care Center Leinfelden-Echterdingen GmbH, Nikolaus-Otto-Straße 6, 70771 Leinfelden-Echterdingen / Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eberhard Wieland
Christian Mayer
4SYNLAB Holding Deutschland GmbH, Gubener Straße 39, 86156 Augsburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caren Mutschmann
8SGS Analytics Germany GmbH, Turmstraße 21, 10559 Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Roskos
4SYNLAB Holding Deutschland GmbH, Gubener Straße 39, 86156 Augsburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans-Jörg Wertenauer
1Hausärzte am Schillerplatz, Hauptstraße 5, 70563 Stuttgart-Vaihingen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Winfried März
2Medical Clinic V, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany
9SYNLAB Academy, SYNLAB Holding Deutschland GmbH, P5,7, 68161 Mannheim
10Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Winfried März
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Widely available rapid testing is pivotal to the fight against COVID-19. Real-time reverse transcription-polymerase chain reaction (rRT-PCR) remains the gold standard. We compared two frequently used commercial rapid diagnostic tests (RDTs) for SARS-CoV-2-antigens, the SD Biosensor SARS-CoV-2 Rapid Antigen Test (Roche Diagnostics) and the Panbio COVID-19 Ag Rapid Test (Abbott Diagnostics), against rRT-PCR for SARS-CoV-2 detection.

Methods We compared the tests in 2215 all-comers at a diagnostic centre between February 1 and March 31, 2021. rRT-PCR-positive samples were examined for SARS-CoV-2 variants.

Findings 338 participants (15%) were rRT-PCR-positive for SARS-CoV-2. The sensitivities of Roche-RDT and Abbott-RDT were 60.4% and 56.8% (P<0·0001) and specificities 99.7% and 99.8% (P=0·076), respectively. Sensitivity inversely correlated with rRT-PCR-derived Ct values. Unadjusted, the RDTs had higher sensitivities in individuals referred by treating physicians and health departments than those tested for other reasons, in persons without comorbidities compared to those with comorbidities, in individuals with symptoms suggesting COVID-19, and in the absence of SARS-CoV-2 variants compared to Alpha variant carriers. The associations of sensitivity with clinical symptoms and the SARS-CoV-2 genotype were robust against adjustment for Ct values. Assuming that 10 000 symptomatic individuals are tested, 500 of which are truly positive, the RDTs would generate 38 false-positive and 124 false-negative results. Assuming that 10 000 asymptomatic individuals are tested, including 50 true positives, 18 false-positives and 34 false-negatives would be generated.

Interpretation The sensitivities of the two RDTs are unsatisfactory. This calls into question whether their widespread use is effective in the ongoing SARS-CoV-2 pandemic.

Funding SYNLAB Holding Deutschland GmbH

Evidence before this study Small studies and a meta-analysis from the Cochrance collaboration indicate vastly different diagnostic efficacies of commercial rapid diagnostic tests (RDTs) for SARS-CoV-2 antigen. The impact of SARS-CoV-2 variants has not been known.

Added value of this study This is one of the largest real-world studies of the diagnostic efficacy of two widely recommended RDTs SARS-CoV-2 antigen in comparison to rRT-PCR. The sensitivities of the two RDTs are unsatisfactory, mainly in asymptomatic persons. Presence of the SARS-CoV-2 Alpha Variant decreased both tests’ sensitivities significantly.

Implications of all the available evidence Policy and health care providers should account for substantial limitations of RDTs for SARS-CoV-2 particular in asymptomatic persons. Research into alternative approaches to the screening for SARS-CoV-2 should be intensified.

Competing Interest Statement

All authors except Hans-Joerg Wertenauer and Caren Mutschmann are employed by SYNLAB Holding Germany GmbH or its regional subsidiaries. There are no other known conflicts of interest associated with this publication. There was no financial support to SYNLAB or any of its employees from the manufacturers of the assays used in this evaluation, and there has been no other financial support for this work that could have influenced its outcome.

Clinical Protocols

https://www.synlab.de/human/news-artikel/veroeffentlichung-des-protokolls-der-covid-19-antigen-studie-1398

Funding Statement

The costs of the study were defrayed by SYNLAB Holding Deutschland GmbH. The management had no role in writing of the report or the decision to submit for publication. There was no financial support to SYNLAB Holding Deutschland GmbH from the manufacturers of the assays used in this evaluation and there has been no other financial support for this work that could have influenced its outcome. All authors had full access to all data and assume final responsibility for the decision to submit for publication.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by Ethics Committee II (Mannheim) of the University of Heidelberg (reference number 2020-417MF) and the German Institute for Drugs and Medical Devices.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data will be made available to researchers upon justified request and formal agreement to make sure that rules of good scientific practice are obeyed and that credit is given to the people who have been in charge of the design and the organization of the study. Interested researchers are invited to address their request or proposal to Prof. Dr. med. Winfried Maerz (winfried.maerz{at}synlab.com). The authors confirm that they accessed and validated these data and that all other researchers can access the data in the same manner the authors did.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 07, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Diagnostic Efficacy of Rapid Antigen Testing for SARS-CoV-2: The COVid-19 AntiGen (COVAG) study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Diagnostic Efficacy of Rapid Antigen Testing for SARS-CoV-2: The COVid-19 AntiGen (COVAG) study
Christoph Wertenauer, Geovana Brenner Michael, Alexander Dressel, Caroline Pfeifer, Ulrike Hauser, Eberhard Wieland, Christian Mayer, Caren Mutschmann, Martin Roskos, Hans-Jörg Wertenauer, Winfried März
medRxiv 2021.08.04.21261609; doi: https://doi.org/10.1101/2021.08.04.21261609
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Diagnostic Efficacy of Rapid Antigen Testing for SARS-CoV-2: The COVid-19 AntiGen (COVAG) study
Christoph Wertenauer, Geovana Brenner Michael, Alexander Dressel, Caroline Pfeifer, Ulrike Hauser, Eberhard Wieland, Christian Mayer, Caren Mutschmann, Martin Roskos, Hans-Jörg Wertenauer, Winfried März
medRxiv 2021.08.04.21261609; doi: https://doi.org/10.1101/2021.08.04.21261609

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (579)
  • Anesthesia (140)
  • Cardiovascular Medicine (1947)
  • Dentistry and Oral Medicine (252)
  • Dermatology (185)
  • Emergency Medicine (333)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (700)
  • Epidemiology (11108)
  • Forensic Medicine (8)
  • Gastroenterology (626)
  • Genetic and Genomic Medicine (3182)
  • Geriatric Medicine (309)
  • Health Economics (563)
  • Health Informatics (2043)
  • Health Policy (863)
  • Health Systems and Quality Improvement (782)
  • Hematology (310)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12729)
  • Intensive Care and Critical Care Medicine (707)
  • Medical Education (317)
  • Medical Ethics (92)
  • Nephrology (336)
  • Neurology (2993)
  • Nursing (164)
  • Nutrition (465)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1556)
  • Ophthalmology (478)
  • Orthopedics (185)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (403)
  • Pediatrics (914)
  • Pharmacology and Therapeutics (382)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2789)
  • Public and Global Health (5597)
  • Radiology and Imaging (1095)
  • Rehabilitation Medicine and Physical Therapy (635)
  • Respiratory Medicine (761)
  • Rheumatology (339)
  • Sexual and Reproductive Health (311)
  • Sports Medicine (289)
  • Surgery (343)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (133)